SCHEMBL27255485

SCHEMBL27255485

CNS(=O)(=O)c1cnc2c(ccn2-c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
PTK2 Q05397 2/20 0.43
TNNI3K Q59H18 2/20 0.42
TEAD1 P28347 1/20 0.41
YAP1 P46937 1/20 0.41
LCK P06239 1/20 0.36
KIT P10721 1/20 0.36
SRC P12931 1/20 0.36
KDR P35968 1/20 0.36
SLC40A1 Q9NP59 2/20 0.36
ALDH1A1 P00352 1/20 0.35
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
HSD11B1 P28845 1/20 0.35
OXTR P30559 1/20 0.35
AVPR1A P37288 1/20 0.35
PTGS2 P35354 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
BRAF P15056 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27255480 0.84 PTK2 (0.40) PTK2LCKKITSRCKDR
SCHEMBL27255168 0.79 KCNH2 (0.48) MAPTTNNI3KTEAD1YAP1ALDH1A1
SCHEMBL27255497 0.78 MAPT (0.41) MAPTTNNI3KTEAD1YAP1ALOX5AP
SCHEMBL30839910 0.78 MAPT (0.41) MAPTTNNI3KTEAD1YAP1ALOX5AP
SCHEMBL27255482 0.77 PTK2 (0.45) PTK2LCKKITSRCKDR
SCHEMBL16167709 0.75 PTK2 (0.46) PTK2LCKKITSRCKDR
SCHEMBL14136858 0.74 PTK2 (0.44) PTK2LCKKITSRCKDR
SCHEMBL31591370 0.74 PTK2 (0.44) PTK2LCKKITSRCKDR
SCHEMBL27255478 0.72 PTK2 (0.42) PTK2LCKKITSRCKDR
SCHEMBL26108209 0.71 NR3C1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120051465-A Novel heterobicyclic compounds for inhibiting YAP-TEAD interactions and pharmaceutical compositions containing the same 韩美药品株式会社 2025-05-27 CN disclosed
WO-2024080792-A1 NOVEL HETEROBICYCLIC COMPOUND FOR INHIBITING YAP-TEAD INTERACTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME HANMI PHARM. CO., LTD. (KR) 2024-04-18 WO disclosed